Organization and Business (Details Narrative)	1 Months Ended	3 Months Ended	6 Months Ended	12 Months Ended
	May 28, 2021 USD ($)	Jun. 30, 2023 USD ($) shares	Jun. 30, 2023 USD ($) integer shares	Dec. 31, 2022 USD ($)	Mar. 31, 2021 USD ($)
Number of patents issued | integer			19
Number of share sold | shares			16,000,000
Cash and cash equivalents		$ 5,000,000	$ 5,000,000		$ 2,000,000
Interest bearing account cash					$ 10,000,000
Net working capital		2,000,000	2,000,000
Accumulated deficit		$ 163,874,901	163,874,901	$ 157,057,558
Gross proceeds from credit facility from bank draft			4,000,000.0
Common Stocks [Member]
Sale of stock, consideration received on transaction, authorized amount	$ 14,611,900
Number of share sold | shares		173,558
Commission Fee, Percent	3.00%
Period For Which Advance Notice Is Due To Terminate Agreement	10 days
Number of share sold amount		$ 63,136
Agent commission		1,902
Investment Management Company [Member]
Cash and cash equivalents		$ 467,000	$ 467,000
Customer One, Two, and Three | Net Revenue | Customer Concentration Risk
Percentage of concentration risk		78.60%	73.50%
Customer One, Two, and Three | Accounts Receivable | Customer Concentration Risk
Percentage of concentration risk			47.30%	23.90%
Customer One | Net Revenue | Customer Concentration Risk
Percentage of concentration risk		54.00%	42.50%
Customer Two | Net Revenue | Customer Concentration Risk
Percentage of concentration risk		16.90%	20.40%
Customer Three | Net Revenue | Customer Concentration Risk
Percentage of concentration risk		7.70%	10.60%